BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2014 2:06:00 PM | Browse: 1355 | Download: 1358
 |
Received |
|
2013-12-26 16:00 |
 |
Peer-Review Started |
|
2013-12-27 09:38 |
 |
To Make the First Decision |
|
2014-01-08 14:03 |
 |
Return for Revision |
|
2014-01-17 11:40 |
 |
Revised |
|
2014-01-23 10:01 |
 |
Second Decision |
|
2014-06-18 15:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-06-18 15:29 |
 |
Articles in Press |
|
2014-06-18 15:52 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-07-24 14:16 |
 |
Publish the Manuscript Online |
|
2014-12-11 14:23 |
Category |
Oncology |
Manuscript Type |
Minireviews |
Article Title |
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tokujiro Yano, Tatsuro Okamoto, Seiichi Fukuyama and Yoshihiko Maehara |
Funding Agency and Grant Number |
|
Corresponding Author |
Tokujiro Yano, MD at the Department of Thoracic Surgery, National Hospital Organization Beppu Medical Center, 1473 Uchikamado, Beppu, 874-0011, Japan.
e-mail: tokujiro@beppu.hosp.go.jp
|
Key Words |
Non-small cell lung cancer; Postoperative recurrence; Distant metastasis; Oligometastases; Local treatment; Locoregional recurrence |
Core Tip |
The postrecurrence survival in non-small cell lung cancer (NSCLC) is considered to largely depend on both the mode of first recurrence (distant, locoregional or combined) and the treatment modality. Therefore, the therapeutic strategy for treating postoperative recurrence in patients with NSCLC should be considered according to the mode of first recurrence. In this way, proper treatment specific to the mode of recurrence will be developed and improvements of the postrecurrence survival can be obtained. |
Publish Date |
2014-12-11 14:23 |
Citation |
Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol 2014; 5(5): 1048-1054 |
URL |
http://www.wjgnet.com/2218-4333/full/v5/i5/1048.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v5.i5.1048 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345